KI-Beratung Beta
Vor Ort
Merkzettel Warenkorb
Produktbild: New Oxford Textbook of Psychiatry

New Oxford Textbook of Psychiatry

457,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

09.06.2020

Herausgeber

John R. Geddes + weitere

Verlag

Oxford Academic

Seitenzahl

1536

Maße (L/B/H)

28,2/23/6 cm

Gewicht

3655 g

Auflage

3rd edition

Sprache

Englisch

ISBN

978-0-19-871300-5

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

09.06.2020

Herausgeber

Verlag

Oxford Academic

Seitenzahl

1536

Maße (L/B/H)

28,2/23/6 cm

Gewicht

3655 g

Auflage

3rd edition

Sprache

Englisch

ISBN

978-0-19-871300-5

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: New Oxford Textbook of Psychiatry

    • Section 1: The subject matter and approach to psychiatry
    • 1: Kay Redfield Jamison and Adam Ian Kaplin: The patient's perspective
    • 2: Nicole Votruba, Mirja Koschorke, and Graham Thornicroft: Public attitudes and the challenge of stigma
    • 3: Crick Lund, Dörte Bemme, and Judy Bass: Global mental health
    • 4: Pierre Pichot: The history of psychiatry as a medical specialty
    • 5: Ilina Singh, Julian Savulescu, and Matthew L. Baum: A new ethics for 21st century psychiatry
    • 6: Hans-Jürgen Möller: Foundations of phenomenology / descriptive psychopathology
    • 7: Darrel A. Regier, David P. Goldberg, Geoffrey M. Reed and Bedirhan T. Ustun: DSM-5 and ICD-11 classifications
    • 8: Charles A. Sanislow, Sarah E. Morris, Jennifer Pacheco, and Bruce N. Cuthbert: The National Institute of Mental Health Research Domain Criteria: An alternative framework to guide psychopathology research
    • 9: Andrea Cipriani, Stefan Leucht, and John R. Geddes: Application of research evidence in clinical practice
    • 10: Guy M. Goodwin, Joseph Zohar, and David J. Kupfer: A neuroscience based nomenclature for psychotropic drugs
    • Section 2: The scientific basis of psychiatric aetiology and treatment
    • 11: Karl Zilles and Nicola Palomero-Gallagher: Neuroanatomy
    • 12: Mark Woolrich, Mark Jenkinson, and Clare Mackay: Neuroimaging technologies
    • 13: Olaf Sporns: The connectome
    • 14: Trevor Sharp: Neurotransmitters and signalling
    • 15: Juan C. Leza, Javier R. Caso, and Borja García-Bueno: Psychoneuroimmunology
    • 16: Caleb Webber: Functional genomics
    • 17: Anna Christina Nobre: Cognitive neuroscience: Principles and methods
    • 18: Verena Heise, Enik? Zsoldos, and Klaus P. Ebmeier: Ageing and the human brain
    • 19: Helen S. Mayberg, Andrea Cowell, and Patricio Riva Posse: Development of brain stimulation
    • 20: Amy Chan and Rob Horne: Adherence to treatment in psychiatry
    • Section 3: Intellectual disabilities
    • 21: Anthony J. Holland: Core dimensions of intellectual disabilities
    • 22: Sally-Ann Cooper: Epidemiology and course of intellectual disabilities
    • 23: Judith L. Rapoport, Dale Zhou, and Kwangmi Ahn: Aetiology of intellectual disability: General issues and prevention
    • 24: José-Luis Ayuso-Mateos and Cary S. Kogan: Management and treatment of intellectual disability
    • Section 4: Autism spectrum disorders
    • 25: Fred R. Volkmar and Scott L. J. Jackson: Core dimensions of autism spectrum disorders
    • 26: Emily J. H. Jones: Basic mechanisms and treatment targets for autism spectrum disorders
    • 27: Charles R. Newton: Epidemiology of autism
    • 28: Abha R. Gupta, Thomas V. Fernandez, and Ellen J. Hoffman: Genetics of autism spectrum disorders
    • 29: Christine Eckera and Declan Murphy: Imaging of autism spectrum disorders
    • 30: Emily Simonoff: Management and treatment of autism spectrum disorders
    • Section 5: Attention deficit and hyperactivity disorder
    • 31: Eric Taylor: Core dimensions of attention deficit hyperactivity disorder
    • 32: Barbara Franke and Jan K. Buitelaar: Basic mechanisms and treatment planning / targets for attention deficit hyperactivity disorder
    • 33: Guilherme V. Polanczyk: Epidemiology of attention deficit hyperactivity disorder and the implications for its prevention
    • 34: Kate Langley and Anita Thapar: Genetics of attention deficit hyperactivity disorder
    • 35: Philip Shaw and Eszter Szekely: Insights from neuroanatomical imaging into attention deficit hyperactivity disorder throughout the lifespan
    • 36: Alessandro Zuddas and Sara Carucci: Management and treatment of attention deficit hyperactivity disorder
    • Section 6: Motor disorders
    • 37: Davide Martino and Antonella Macerollo: Neurodevelopmental motor disorders
    • Section 7: Delirium, dementia, and other cognitive disorders
    • 38: Noel J. Buckley and George K. Tofaris: Pathways of neurodegeneration underlying dementia
    • 39: Ravi S. Bhat and Kenneth Rockwood: Delirium
    • 40: Ivan Koychev and John Gallacher: Alzheimer's disease
    • 41: Akitoshi Takeda and Bruce Miller: Frontotemporal dementias
    • 42: Akin Nihat, TzeHow Mok, and John Collinge: Prion disease
    • 43: Anto P. Rajkumar and Dag Aarsland: Dementia with Lewy bodies
    • 44: Michele Hu and Fahd Baig: Dementia in Parkinson's disease
    • 45: Russell L. Margolis: Dementia due to Huntington's disease
    • 46: Joanne A. Byars and Ricardo E. Jorge: Vascular cognitive impairment
    • 47: Christian Lepage, Inga K. Koerte, Vivian Schultz, Michael J. Coleman, and Martha E. Shenton: Traumatic brain injury
    • Section 8: Substance use disorders
    • 48: Trevor W. Robbins and Barry J. Everitt: Substance use disorders and the mechanisms of drug addiction
    • 49: Yann Le Strat, Nicolas Ramoz, and Philip Gorwood: Genetics of substance use disorders
    • 50: Wim van den Brink and Falk Kiefer: Alcohol use disorder
    • 51: Michael Farrell, Briony Larance, and Courtney Breen: Opiates: Heroin, methadone, buprenorphine
    • 52: David J. Castle: Cannabis and mental illness
    • 53: Adam R. Winstock and Remy Flechais: Stimulants, ecstasy, and other party drugs
    • 54: Adam Winstock and James Rucker: Psychedelics and dissociative substances
    • 55: Marcus Munafo and Meryem Grabski: Tobacco addiction
    • 56: Julia M. A. Sinclair and Anne Lingford-Hughes: Co-morbidity of substance use and psychiatric disorders
    • Section 9: Schizophrenia and psychotic disorders
    • 57: Nancy C. Andreasen: The core dimensions of schizophrenia
    • 58: Assen Jablensky: Epidemiology and course of schizophrenia
    • 59: Kimberley M. Kendall, James T. R. Walters and Michael C. O Donovan: Genetics of schizophrenia
    • 60: Andreea O. Diaconescu, Sandra Iglesias, and Klaas E. Stephan: Structural and functional neuroimaging of schizophrenia
    • 61: William S. Stone, Stephen V. Faraone and Ming T. Tsuang: Schizoaffective and schizotypal disorders / acute and transient psychotic disorders
    • 62: Andreas Marneros: Delusional disorders
    • 63: Emre Bora, Mahesh Jayaram, and Christos Pantelis: Prevention and early intervention in psychotic disorders
    • 64: Herbert Y. Meltzer and William V. Bobo: Antipsychotic and anticholinergic drugs
    • 65: Joseph P. McEvoy, Kammarauche Asuzu, Daniel W. Bradford, Oliver Freudenreich, and Katherine Moyer: The treatment and management of patients with schizophrenia
    • Section 10: Mood disorders
    • 66: S. Nassir Ghaemi and Sivan Mauer: Diagnosis, classification and differential diagnosis of mood disorders
    • 67: Lars Vedel Kessing: Epidemiology of mood disorders
    • 68: Gin S. Malhi: Primary prevention of mood disorders: Building a target for prevention strategies
    • Section 11: Bipolar disorder
    • 69: Grant C. Churchill, Nisha Singh, and Michael J. Berridge: Basic mechanisms of and treatment targets for bipolar disorder
    • 70: Francis J. MacMahon and Sevilla Detera-Wadlieigh: Genetics of bipolar disorder
    • 71: Mary L. Phillips and Wayne C. Drevets: Neuroimaging of bipolar disorder
    • 72: Eduard Vieta, Isabella Pacchiarotti, and David J. Miklowitz: Management and treatment of bipolar disorder
    • 73: Ian Jones and Arianna Di Florio: Perinatal psychiatry
    • Section 12: Depressive disorders
    • 74: Marcela Pereira, Roberto Andreatini, and Per Svenningsson: Basic mechanisms of and treatment targets for depressive disorders
    • 75: Alison K. Merikangas and Kathleen R. Merikangas: Genetic epidemiology of depression in the molecular era
    • 76: Guy M. Goodwin and Michael Browning: Imaging of depressive disorders
    • 77: Philip J. Cowen: Management and treatment of depressive disorders
    • Section 13: Trauma and stress or related and adjustment disorders
    • 78: Dean G. Kilpatrick, Matthew J. Friedman, and Amanda K. Gilmore: Classification and descriptive psychopathology of posttraumatic stress disorder and other stressor-related disorders
    • 79: Bruce S. McEwen: Basic mechanisms of and treatment targets for stress-related disorders
    • 80: Michael G. Gottschalk and Katharina Domschke: Genetics of stress-related disorders
    • 81: Navneet Kaur, Cecilia Hinojosa, Julia Russell, Michael B. Van Elzakker, and Lisa M. Shin: Imaging of stress-related disorders
    • 82: Maria Bragesjö, Emily A. Holmes, Filip Arnberg, and Erik M. Andersson: Primary prevention and epidemiology of trauma and stress related disorders
    • 83: Leigh van den Heuvel and Soraya Seedat: Management and treatment of stress-related disorders
    • 84: Beverley Raphael, Sally Wooding, and Julie Dunsmore: Bereavement
    • 85: Deborah Davis and Elizabeth F. Loftus: Recovered memories and false memories
    • Section 14: Anxiety disorders
    • 86: Nastassja Koen and Dan J. Stein: Core dimensions of anxiety disorders
    • 87: Martien Kas and Berend Olivier: Basic mechanisms, genetics, targets and animal models for anxiety disorders
    • 88: Hans-Ulrich Wittchen and Katja Beesdo-Baum: Epidemiology and course of anxiety disorders
    • 89: Michael G. Gottschalk and Katharina Domschke: Genetics of anxiety disorders
    • 90: Gregor Leicht and Christoph Mulert: Neuroimaging of anxiety disorders
    • 91: Aliza Werner-Seidler, Jennifer L. Hudson, and Helen Christensen: The primary prevention of anxiety disorders
    • 92: David S. Baldwin and Nathan T. M. Huneke: Treatment of anxiety disorders
    • Section 15: Obsessive-compulsive and related disorders
    • 93: Sophie C. Snyder, Eric A. Storch, and Wayne K. Goodman: Core dimensions of obsessive-compulsive disorder
    • 94: Eric Burguière and Luc Mallet: Basic mechanisms of and treatment / planning targets for obsessive-complusive disorder
    • 95: Lior Carmi, Naomi A. Fineberg, Oded Ben-Arush, and Joseph Zohar: Obsessive-compulsive disorder
    • 96: Gerald Nestadt and Jack Samuels: Genetics of obsessive-compulsive disorder
    • 97: Rebbia Shahab and Emily R. Stern: Imaging of obsessive-compulsive disorder
    • 98: Naomi A. Fineberg, Lynne M. Drummond, Jemma Reid, Eduardo Cinosi, Lior Carmi, and Davis N. Mpavaenda: Management and treatment of obsessive-compulsive disorder
    • 99: Lorena Fernández de la Cruz and David Mataix-Cols: Hoarding disorder
    • 100: Megan M. Kelly and Katharine A. Phillips: Body dysmorphic disorder
    • Section 16: Feeding and eating disorders
    • 101: Chris Fairburn and Rebecca Murphy: The eating disorders
    • 102: Johannes Hebebrand, Jochen Antel, and Beate Herpertz-Dahlmann: Basic mechanisms and potential for treatment of weight and eating disorders
    • 103: Katherine A Halmi: Epidemiology and primary prevention of feeding and eating disorders
    • 104: Christopher Hüble, Cynthia Bulik, and Gerome Breen: Genetics of feeding and eating disorders
    • 105: Natalie Kurniadi, Christina E. Wierenga, Laura A. Berner, and Walter H. Kaye: Imaging of feeding and eating disorders
    • 106: Susan L. McElroy, Anna I. Guerdjikova, Nicole Mori, Paul L. Houser, and Paul E. Keck, Jr.: Management and treatment of feeding and eating disorders
    • 107: Jamie Hartmann-Boyce, Nerys M. Astbury, and Susan A. Jebb: Aetiology and management of obesity
    • 108: Alexander von Gontard: Elimination disorders in children and adolescents
    • Section 17: Sleep wake disorders
    • 109: David Pritchett, Angus S. Fisk, Russell G. Foster, and Stuart N. Peirson: Basic mechanisms of and treatment targets for sleep-wake disorders
    • 110: Kirstie Anderson: Diagnosis of sleep and circadian rhythm disorder
    • 111: Lena Katharina Keller, Eva C. Winnebeck, and Till Roenneberg: Epidemiology of sleep-wake and primary prevention of its disorders
    • 112: Diego R. Mazzotti, Allan I. Pack, and Philip R. Gehrman: Genetics of sleep-wake disorders
    • 113: Umberto Moretto, Dylan Smith, Liliana Dell Osso, and Thien Thanh Dang-Vu: Multi-modal imaging of sleep-wake disorders
    • 114: Simon D. Kyle, Alasdair L. Henry, and Colin A. Espie: Management of insomnia and circadian rhythm sleep-wake disorders
    • Section 18: Sexual function and sexual dysfunction
    • 115: Cynthia A. Graham and John Bancroft: The sexual dysfunctions and paraphilias
    • 116: Els Elaut and Gunter Heylens: Gender dysphoria
    • Section 19: Personality disorders
    • 117: Andrew E. Skodol and Leslie C. Morey: Core dimensions of personality pathology
    • 118: Kate E. A. Saunders and Steve Pearce: Basic mechanisms of and treatment planning / targets for personality disorders
    • 119: Renato D. Alarcón and Brian A. Palmer: Personality disorders: Epidemiology and clinical course
    • 120: C. Robert Cloninger: Genetics of personality disorders
    • 121: Christian Paret and Christian Schmahl: Imaging of personality disorders
    • 122: Giles Newton-Howes and Roger Mulder: Treatment and management of personality disorder
    • Section 20: Impulse control and conduct disorders
    • 123: Donald W. Black: Impulse control and its disorders: including pathological gambling
    • 124: Stephen Scott and Melanie Palmer: Conduct disorders and antisocial personality disorder in childhood and adolescence
    • Section 21: Suicide
    • 125: Merete Nordentoft, Trine Madsen, and Annette Erlangsen: Epidemiology and causes of suicide
    • 126: Nav Kapur, Sarah Steeg, and Adam Moreton: Self-harm: Epidemiology and risk factors
    • 127: J. John Mann and Dianne Currier: Biological aspects of suicidal behaviour
    • 128: Keith Hawton, Kate E. A. Saunders, and Alexandra Pitman: Prevention of suicide and treatment following self-harm
    • Section 22: Somatic symptoms and related disorders
    • 129: Michael Sharpe and Jane Walker: Deconstructing dualism: The interface between physical and psychological illness
    • 130: Chantal Berna and Irene Tracey: Neural mechanisms in chronic pain relevant for psychiatric interventions
    • 131: Jonathan Price: Treatment of fibromyalgia (chronic widespread pain) and chronic fatigue syndrome
    • 132: Thomas Merten and Harald Merckelbach: Factitious disorder and malingering
    • 133: Jon Stone and Michael Sharpe: Functional neurological symptom disorder (Conversion disorder)
    • Section 23: Service provision
    • 134: Martin Knapp: Public policy and service needs in mental health
    • 135: Tom Burns and Tony Kendrick: Planning and providing mental health services for a community
    • 136: Judit Simon: Health economic analysis of service provision
    • 137: William H. Sledge and Julianne Dorset: The organization of psychiatric services for general hospital departments: Proactive and preventive interventions in psychiatry
    • 138: Mina Fazel, Susan Rees, and Derrick Silove: Refugees and populations exposed to mass conflict
    • Section 24: Forensic psychiatry
    • 139: Seena Fazel and Mark Toynbee: Associations between psychiatric disorder and offending
    • 140: Sue Bailey and Prathiba Chitsabesan: Developmental approach to understanding the needs of young people in contact with the criminal justice system
    • 141: Stephen J. Hucker: Child molesters and other sexual offenders
    • 142: Rosemary Purcell and Paul E. Mullen: Stalking and querulous behaviour
    • 143: Louise M. Howard and Deirdre MacManus: Domestic violence and abuse and mental health
    • 144: Alec Buchanan: Assessing and managing the risk of violence towards others
    • 145: John O Grady: The expert witness in the criminal and civil courts
    • 146: Matthew Large and Olav Nielssen: Homicide